Your browser doesn't support javascript.
loading
Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.
Sabbagh, Sara; Almeida de Jesus, Adriana; Hwang, SuJin; Kuehn, Hye Sun; Kim, Hanna; Jung, Lawrence; Carrasco, Ruy; Rosenzweig, Sergio; Goldbach-Mansky, Raphaela; Rider, Lisa G.
Afiliación
  • Sabbagh S; Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, USA.
  • Almeida de Jesus A; Translational Autoinflammatory Diseases Section (TADS), LCIM, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.
  • Hwang S; Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, NIH, Bethesda, MD, USA.
  • Kuehn HS; Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, NIH, Bethesda, MD, USA.
  • Kim H; Pediatric Translational Research Branch, NIAMS, NIH, Bethesda, MD, USA.
  • Jung L; Children's National Health System, Washington, DC, USA.
  • Carrasco R; Pediatric Rheumatology, Specialty for Children, Dell Children's Medical Center, Austin, TX, USA.
  • Rosenzweig S; Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, NIH, Bethesda, MD, USA.
  • Goldbach-Mansky R; Translational Autoinflammatory Diseases Section (TADS), LCIM, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.
  • Rider LG; Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences (NIEHS), NIH, Bethesda, MD, USA.
Brain ; 142(11): e59, 2019 11 01.
Article en En | MEDLINE | ID: mdl-31603187

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Dermatomiositis Límite: Humans Idioma: En Revista: Brain Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Dermatomiositis Límite: Humans Idioma: En Revista: Brain Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido